View Older Stories

May 18, 2026 04:30PM Wave Life Sciences reports trial progress for AATD treatment

Apr 30, 2026 07:12AM WAVE Life Sciences (WVE) PT Lowered to $43 at Canaccord

Apr 29, 2026 11:32AM WAVE Life Sciences (WVE) PT Lowered to $31 at B.Riley

Apr 29, 2026 02:51AM Truist Securities Assumes WAVE Life Sciences (WVE) at Buy

Apr 28, 2026 02:58PM RBC on WAVE Life Sciences (WVE): 'we continue to like the setup'

Apr 28, 2026 01:13PM WAVE Life Sciences (WVE) PT Lowered to $19 at BofA Securities

Apr 28, 2026 12:49PM WAVE Life Sciences (WVE) PT Lowered to $36 at Clear Street

Apr 28, 2026 07:31AM WAVE Life Sciences (WVE) Tops Q1 EPS by 19c

Apr 14, 2026 06:46AM WAVE Life Sciences (WVE) PT Lowered to $18 at H.C. Wainwright

Mar 31, 2026 09:50AM Increasing unusual call option volume: PROP AUTL TERN MKC PRGS CANE WTI WVE AMTX

Mar 27, 2026 06:55AM WAVE Life Sciences (WVE) PT Lowered to $15 at Wedbush, Removed from best Ideas List

Mar 27, 2026 05:04AM RBC on WAVE Life Sciences (WVE): 't we continue to see a molecule that is pharmacologically active and remain optimistic'

Mar 26, 2026 04:21PM WAVE Life Sciences (WVE) PT Lowered to $39 at Clear Street, 'we think ‘007 should find its optimal patient population'

Mar 26, 2026 02:47PM WAVE Life Sciences (WVE) PT Lowered to $25 at Leerink Partners

Mar 26, 2026 02:33PM TD Cowen on Arrowhead Pharma (ARWR): 'We remain at Buy as the pipeline remains robust'

Mar 26, 2026 02:01PM WAVE Life Sciences (WVE) PT Lowered to $18 at Jefferies

Mar 26, 2026 12:30PM WAVE Life Sciences (WVE) PT Lowered to $21 at BofA Securities

Mar 26, 2026 12:23PM B.Riley on WAVE Life Sciences (WVE): 'a ~60% intraday selloff that, in our view, is significantly overdone'

Mar 26, 2026 11:31AM WAVE Life Sciences (WVE) PT Lowered to $12 at Raymond James

Mar 26, 2026 09:37AM Jefferies on WAVE Life Sciences (WVE): 'near-term pressure on stock'

Mar 26, 2026 09:00AM Leerink Partners on WAVE Life Sciences (WVE) after obesity data disappoints: selloff 'very overdone'

Mar 26, 2026 08:55AM Jones Trading on WAVE Life Sciences (WVE) GLP-1: 'we still see the chance for utility in elderly or patients with metabolic disease'

Mar 26, 2026 08:52AM Leerink on WAVE Life Sciences (WVE) Amid 52pct Collapse: 'The stock's reaction premarket... is very overdone in our opinion'

Mar 26, 2026 08:20AM Oppenheimer on WAVE Life Sciences (WVE): 'we would be buyers any weakness'

Mar 25, 2026 11:56AM Jefferies on WAVE Life Sciences (WVE): 'We see reasonable bars for WVE's RNA editor to approach target protein levels'

Mar 24, 2026 04:56PM WAVE Life Sciences (WVE) PT Raised to $27 at Mizuho

Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'

Mar 6, 2026 06:26AM Citi Opens Catalyst Watch on WAVE Life Sciences (WVE)

Mar 5, 2026 08:30AM Wave Life Sciences to present WVE-006 trial data at medical conference

Feb 26, 2026 07:32AM WAVE Life Sciences (WVE) Misses Q4 EPS by 3c

Feb 5, 2026 09:29AM BofA Securities Starts WAVE Life Sciences (WVE) at Buy

Feb 3, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)

Feb 3, 2026 06:35AM WAVE Life Sciences (WVE) PT Raised to $43 at Canaccord Genuity

Feb 2, 2026 01:16PM Raymond James: 'WVE regains full economic rights to WVE-006 from GSK'

Feb 2, 2026 12:26PM WAVE Life Sciences (WVE) PT Raised to $50 at Clear Street

Feb 2, 2026 07:30AM Wave regains full control of WVE-006 drug from GSK partnership

Jan 12, 2026 07:33AM Wave Life Sciences outlines 2026 priorities for obesity drug development

Jan 7, 2026 04:54AM WAVE Life Sciences (WVE) PT Raised to $26 at Raymond James

Jan 6, 2026 01:41PM Clear Street Reiterates Buy Rating on WAVE Life Sciences (WVE)

Jan 6, 2026 11:03AM WAVE Life Sciences (WVE) call put ratio 2.7 calls to 1 put with a focus on January 19 calls as share price up 17%

Dec 16, 2025 06:07AM WAVE Life Sciences (WVE) PT Raised to $32 at Oppenheimer

Dec 15, 2025 06:18AM WAVE Life Sciences (WVE) PT Raised to $50 at Truist Securities

Dec 12, 2025 06:44AM WAVE Life Sciences (WVE) PT Raised to $33 at Wedbush, Added to BIL

Dec 12, 2025 03:38AM Jefferies Reiterates Buy Rating on WAVE Life Sciences (WVE)

Dec 11, 2025 11:46AM WAVE Life Sciences (WVE) PT Raised to $37 at B.Riley

Dec 9, 2025 06:21AM WAVE Life Sciences (WVE) PT Raised to $40 at Canaccord Genuity

Dec 9, 2025 06:17AM WAVE Life Sciences (WVE) PT Raised to $30 at Citi

Dec 9, 2025 05:27AM Increasing unusual call option volume: WVE WRBY CRH PLAB AMLP AM CNM ELAN GPCR

Dec 9, 2025 04:13AM WAVE Life Sciences (WVE) PT Raised to $21 at Raymond James

Dec 9, 2025 12:53AM RBC Capital Upgrades WAVE Life Sciences (WVE) to Outperform

View Older Stories